RTW INVESTMENTS, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001493215

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2023 · 64 positions · Total reported value $6.40B · Top-10 concentration 53.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.2% · 10 new · 12 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.3% · vs SPY -9.4% · Prev Value $11.71B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $9.91B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, RTW INVESTMENTS, LP disclosed 64 equity positions with a combined reported value of $6.40B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 53.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were RCKT ($530.10M), IMCR ($416.51M), MRTX ($397.65M). By sector, the heaviest allocations are Health Care 73.5%, Industrials 6.0%. Versus the prior quarter, allocation shifted toward Other (+2.6pp) and away from Industrials (-2.8pp).

Versus the prior quarter, RTW INVESTMENTS, LP opened 10 new positions, trimmed 12 and fully exited 13, a turnover rate of 37.2% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q4 2023 were ARVN ($173.43M), CRGX ($119.82M), AKRO ($83.89M).

Of the 13 positions fully exited versus the prior quarter, the largest were MLTX ($28.50M), ILMN ($25.83M), AXNX ($24.83M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • ARVN ARVINAS INC · $173.43M
  • CRGX CARGO THERAPEUTICS INC · $119.82M
  • AKRO AKERO THERAPEUTICS INC · $83.89M
  • ETNB 89BIO INC · $62.32M
  • SYRE SPYRE THERAPEUTICS INC · $48.05M
  • DHR DANAHER CORP DEL · $27.43M
  • RDNT RADNET INC · $23.07M
  • SWTX SPRINGWORKS THERAPEUTICS INC · $22.81M

Fully Exited (vs previous quarter)

  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $28.50M
  • ILMN ILLUMINA INC · prev qtr: $25.83M
  • AXNX AXONICS INC · prev qtr: $24.83M
  • SCPH SCPHARMACEUTICALS INC · prev qtr: $23.48M
  • PMVP PMV PHARMACEUTICALS INC · prev qtr: $14.59M
  • OM OUTSET MED INC · prev qtr: $8.80M
  • MLYS MINERALYS THERAPEUTICS INC · prev qtr: $8.77M
  • SYK STRYKER CORPORATION · prev qtr: $7.65M

Insider Transactions (Form 4)

Latest RTW INVESTMENTS, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-09 Buy Orchestra BioMed Holdings, Inc. 1,200,000 $5.00 SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 1,771 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 19,934 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 161,807 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 209,254 — SEC filing
2026-04-27 Sell Orchestra BioMed Holdings, Inc. 32 $4.13 SEC filing
2026-04-27 Opt exercise Orchestra BioMed Holdings, Inc. 1,250,032 $0.00 SEC filing
2026-04-20 Buy Kailera Therapeutics, Inc. 500,000 $16.00 SEC filing

All insider transactions →

Fund Profile

RTW Investments, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 84 positions worth $11.71B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78183 (status: Approved), registered 2013-06-13
  • Regulatory AUM (Form ADV): $14.14B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds
  • Website: rtwfunds.com

Portfolio Structure

  • 84 positions · $11.71B reported value (Q2 2026)
  • Top 10 holdings = 47.7% of reported value
  • Largest position: MDGL (MADRIGAL PHARMACEUTICALS INC) at 9.1%
  • Average position size: $139.44M

Sector Tilt

  • Health Care 99.1%
  • Industrials 0.4%
  • Information Technology 0.4%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 9 new, 24 added, 8 reduced, 13 exited
  • 43 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 73.5%
Other 20.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 17.69M $530.10M 8.28%
8.28%
Hold
2 6.10M $416.51M 6.51%
6.51%
Hold
3 6.77M $397.65M 6.21%
6.21%
Hold
4 4.49M $357.33M 5.58%
5.58%
Hold
5 11.25M $352.35M 5.50%
5.50%
Reduce
6 6.89M $329.34M 5.14%
5.14%
Add
7 1.64M $314.02M 4.91%
4.91%
Reduce
8 667.20K $253.82M 3.96%
3.96%
Add
9 3.34M $245.72M 3.84%
3.84%
Reduce
10 2.53M $210.82M 3.29%
3.29%
Reduce
11 7.42M $204.60M 3.20%
3.20%
Add
12 815.19K $188.62M 2.95%
2.95%
Add
13 4.21M $173.43M 2.71%
2.71%
New
14 1.46M $171.41M 2.68%
2.68%
Reduce
15 662.66K $166.69M 2.60%
2.60%
Reduce
16 2.59M $162.45M 2.54%
2.54%
Reduce
17 3.46M $137.35M 2.15%
2.15%
Hold
18 5.32M $121.88M 1.90%
1.90%
Reduce
19 5.18M $119.82M 1.87%
1.87%
New
20 3.21M $114.41M 1.79%
1.79%
Reduce
21 5.20M $112.62M 1.76%
1.76%
Add
22 3.90M $108.23M 1.69%
1.69%
Add
23 6.95M $98.10M 1.53%
1.53%
Reduce
24 1.55M $86.74M 1.35%
1.35%
Add
25 3.59M $83.89M 1.31%
1.31%
New
26 2.37M $65.27M 1.02%
1.02%
Add
27 2.49M $64.57M 1.01%
1.01%
Hold
28 3.15M $63.83M 1.00%
1.00%
Add
29 5.58M $62.32M 0.97%
0.97%
New
30 6.69M $60.54M 0.95%
0.95%
Hold
31 2.14M $59.86M 0.94%
0.94%
Hold
32 1.87M $57.80M 0.90%
0.90%
Hold
33 5.62M $51.32M 0.80%
Form 4 · 1 →
0.80%
Hold
34 2.23M $48.05M 0.75%
0.75%
New
35 5.47M $36.92M 0.58%
0.58%
Reduce
36 16.89M $29.90M 0.47%
0.47%
Hold
37 118.58K $27.43M 0.43%
0.43%
New
38 50.00K $26.54M 0.41%
0.41%
Reduce
39 1.73M $25.90M 0.41%
0.41%
Add
40 663.60K $23.07M 0.36%
0.36%
New
41 625.00K $22.81M 0.36%
0.36%
New
42 4.13M $21.73M 0.34%
0.34%
Reduce
43 1.97M $19.47M 0.30%
0.30%
New
44 3.33M $19.30M 0.30%
0.30%
Hold
45 1.45M $16.33M 0.26%
0.26%
Reduce
46 1.48M $15.64M 0.24%
0.24%
Add
47 2.30M $15.17M 0.24%
0.24%
New
48 492.98K $13.34M 0.21%
0.21%
Reduce
49 605.82K $13.19M 0.21%
0.21%
New
50 3.46M $12.93M 0.20%
0.20%
Hold

FAQ

What did RTW INVESTMENTS, LP buy in 2023-Q4?

In its 2023-Q4 13F filing, RTW INVESTMENTS, LP reported 64 equity positions worth $6.40B in aggregate; its largest disclosed positions were RCKT ($530.10M), IMCR ($416.51M), MRTX ($397.65M).

How large is RTW INVESTMENTS, LP's portfolio?

RTW INVESTMENTS, LP reported $6.40B of long equity holdings across 64 positions as of 2023-Q4. Top-10 holdings account for 53.2% of reported value.

What is RTW INVESTMENTS, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rtw-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →